张韶壬

张韶壬 discloses dealings in Duality Biotherapeutics, Inc. - B to HKEX. The record holds 3 filings, for trades running from 15 April 2025 to 16 January 2026.

Sales make up the whole of the open-market record (1 sale, €5.9M). So far in 2026, the count stands at no purchases and 1 sale.

On 16 January 2026 came the latest disclosure, an open-market sale for €5.9M in Duality Biotherapeutics, Inc. - B. Filings reach the HKEX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.